Boston University Social Innovation on Drug Resistance Program
Advocate Member
Drug resistance is an inevitable biological process driven by evolution, but made worse by human behavior, threatening to usher in a post-antibiotic era. While the new products created from the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator s (CARB-X) preclinical product development support are an important step in preventing that; an equally important challenge is to understand the impact of human behavior on the evolution of drug-resistant microbes. The tools for this effort will be interdisciplinary, rooted in the social sciences.
To advance these important goals, the Institute for Health System Innovation & Policy and CARB-X created the Social Innovation on Drug Resistance (SIDR) Program, an interdisciplinary postdoctoral fellowship program focused on the interaction of human behavior and drug-resistant infections.